View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
HHS/CMS | RIN: 0938-AT59 | Publication ID: Fall 2022 |
Title: Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs for Contract Year 2020; Risk Adjustment Data Validation (CMS-4185) | |
Abstract:
The first final rule set forth programmatic and operational changes to the Medicare Advantage (MA) and prescription drug benefit programs for contract year 2020. The second final rule addresses the Medicare Advantage Risk Adjustment Data Validation provisions. |
|
Agency: Department of Health and Human Services(HHS) | Priority: Economically Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Final Rule Stage |
Major: Yes | Unfunded Mandates: No |
CFR Citation: 42 CFR 422 | |
Legal Authority: 42 U.S.C. 1302 42 U.S.C. 1395hh |
Legal Deadline:
|
||||||||||||||||||||||||||||||
Overall Description of Deadline: MMA section 902 requires Medicare final rules publish within 3 years of a proposed or interim final rule. A notice may publish in the Federal Register before the 3-year deadline extending the timeline. We do not intend to delay publishing the final regulation if we are able to publish it sooner. |
||||||||||||||||||||||||||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: Federal |
Federalism: No | |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Agency Contact: Joseph Strazzire Health Insurance Specialist Department of Health and Human Services Centers for Medicare & Medicaid Services Center for Program Integrity, MS: AR-22-56, 7500 Security Boulevard, Baltimore, MD 21244 Phone:410 786-2775 Email: joseph.strazzire@cms.hhs.gov |